A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA

Clinical trial NCT03221933 · COMPLETED

Trial details

NCT number: NCT03221933
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small for Gestational Age Infant

Start date: 2009-12-01
Primary completion: 2014-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.